Clinical Trial: A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446153) titled 'A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects' on Feb. 26.

Brief Summary: This study is an open, multicenter, Phase I/II clinical trial, divided into three stages: dose escalation, dose expansion and efficacy expansion.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumor

Intervention: DRUG: HRS-8364 Tablet

HRS-8364 tablet.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....